Skip to main content
Premium Trial:

Request an Annual Quote

OneOme's RightMed Test

OneOme has launched its RightMed test, a 22-gene pharmacogenomic assay intended to be provided as part of routine clinical care. The company said the test can potentially inform treatment decisions across more than 340 medications. OneOme has also developed a platform that allows users to generate a report to guide prescribing using genotype or sequence data obtained elsewhere.

RightMed will be offered through the company's CLIA-registered laboratory in Minneapolis, which it opened in July. OneOme has also entered the market in Puerto Rico, Cuba, and the Dominican Republic through a partnership with High Profile Laboratory in Guaynabo, Puerto Rico. 

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.